Exhibiting at Fi South America 2025

Yosen Indústria e Comércio de Produtos Para Saúde Ltda., based in Ribeirão Preto, São Paulo, Brazil, is an innovation-driven nutraceutical manufacturer specializing in lipid-based delivery systems and advanced functional health supplements. Since its founding in 2020, Yosen has rapidly emerged as a leading startup in Brazil’s health and wellness industry, combining pharmaceutical precision with consumer-friendly formats.

Core Business and Product Portfolio

Yosen designs and produces bioavailable nutraceutical solutions using proprietary encapsulation and delivery technologies. Its portfolio includes ready-to-market supplements, branded actives, and white-label contract manufacturing for domestic and international markets.

1. Advanced Delivery Systems

• Ydrosolv®: A patented lipid-based microemulsion system enhancing the absorption of fat-soluble nutrients like vitamins D3, K2, E, CoQ10, and Astaxanthin
• Creasolv®: Solubilized creatine delivery matrix for improved absorption and GI comfort
• DHAOX®: Omega-3 algae oils with enhanced oxidative stability and high bioavailability (Puro and Algae forms)

2. Finished Nutraceutical Products

• Lipid-formulated drops: Vitamin D3, E, K2, CoQ10, Astaxanthin, Iron, Melatonin, Zinc
• Spray formats: B12, Vitamin C, Multivitamin blends
• Functional blends: Pre-workouts like Pro Energy Boost and Pro Energy Decaf
• Specialized actives: L-Methylfolate, Lutein, DHA (Algae-sourced)

All formulations are designed for rapid sublingual or oral absorption, with a focus on reducing excipients and maximizing efficacy.

Specialization and Unique Selling Proposition

Yosen distinguishes itself through:

• Lipid-based solubilization technology (Ydrosolv®) that increases bioavailability by up to 10x compared to standard formulations
• Innovative dosage formats: oral sprays, lipid-based drops, solubilized concentrates
• Clinically relevant dosages and clean-label ingredients
• Strong focus on taste, texture, and compliance for consumer adherence
• Fast formulation cycles with R&D-to-market agility for B2B and private label clients

Their innovations bridge pharmaceutical standards with consumer wellness demands.

Financial Overview

As a private company and early-stage startup, Yosen’s financials are not publicly disclosed. However:

• Estimated Annual Revenue (2023): USD 1.5–2 million (based on market share and product portfolio)
• Funding: Seed and angel funding rounds raised between 2020–2022
• Production Capacity: 3 million+ units/year across various formats
• Employees: ~30 (including formulation chemists, engineers, and regulatory staff)

The company’s fast-paced expansion has been supported by Brazil’s growing nutraceutical demand and export contracts with regional partners.

Export and Shipment Records

Though shipment data is limited due to the company’s startup phase, verified sources and partner listings confirm:

• Exports initiated in 2023 to Chile, Peru, and Portugal
• Products exported: Ydrosolv®-based Vitamin D3, CoQ10, DHAOX®, Pre-workout concentrates
• Private-label agreements signed with at least 4 international supplement brands

All shipments are accompanied by full compliance documentation, GMP certification, and multilingual labeling options.

Target Markets

Yosen serves:

• Direct-to-Consumer (D2C) channels through its own e-commerce platform
• Retail Health & Organic Stores
• Private Label Supplement Brands
• Sports Nutrition and Functional Beverage Startups
• Exporters and Distributors in LATAM and EU

Their offering caters to health-conscious consumers seeking fast-acting, science-backed, and clean-label supplements.

Capabilities and Facilities

Yosen operates a GMP-certified manufacturing site in Ribeirão Preto, equipped with:

• Microemulsion formulation systems
• Cold processing lines for sensitive lipids and vitamins
• Automated bottling, filling, and spray delivery packaging
• Dedicated R&D lab for stability and solubility testing
• On-site QA/QC and regulatory compliance department

Formulation support includes prototype development, flavor masking, clinical trial references, and regulatory navigation for export markets.

Certifications and Compliance

Yosen maintains high standards of safety and quality:

• GMP Certified
• Anvisa-licensed (Brazilian National Health Surveillance Agency)
• Halal and Kosher-compliant formulations (on demand)
• Non-GMO, Allergen-free, Vegan declarations available
• Compliant with EU, Mercosur, and FDA guidelines for dietary supplements

All product batches include traceable COAs, MSDS, and microbiological and heavy metal test reports.

Customer Testimonials

“Yosen's Ydrosolv® technology helped us deliver vitamin D3 in a format that our clients love. We saw better adherence and faster reorder rates.”
— Brand Manager, Brazilian Health Retail Chain

“Their spray formulations have drastically simplified our supplement routines. Finally, a startup that merges innovation with functionality.”
— Wellness Coach, São Paulo

Major Achievements

• Filed 6 patents related to microemulsion and delivery technologies (2020–2024)
• Recognized as a Top 10 Nutraceutical Startups in Brazil by StartSe (2023)
• Selected for HealthTech acceleration program at InovaHC – Hospital das Clínicas (2022)
• Launched 25+ SKUs within first 3 years of operations
• Partnered with leading Brazilian nutritionists and clinics for product formulation support

Yosen continues to redefine supplement innovation through its pioneering delivery systems, strategic product design, and commitment to health-forward, high-performance formulations.